Glycemic Response to an Innovative Cookie to Promote Human Health

Inclusion Criteria

• •Body mass index (BMI) range 18.5 - 25.0 kg/m2 at screening visit
• •Fasting whole blood glucose values \< 6.3 mmol/L
• •Regular diet with 3 meals a day (at least 5 times a week)
• •Absence of health conditions that would prevent fulfillment of study requirements as judged by the Investigators on the basis of medical history
• •Willingness to maintain habitual diet, physical activity pattern, and body weight throughout the trial
• •Willingness to abstain from alcohol consumption and to avoid vigorous physical activity for 24 h prior to study visits
• •Adequate level of understanding spoken and written English
• •Willingness to report lifestyle factors such as level of physical activity and perceived psychological stress
• •Willingness to provide informed consent to participate in the study
• •Recent participation in any clinical trial (\< 90 days)
• •Pregnant or lactating or wishing to become pregnant in the period of the study
• •Known history of AIDS, hepatitis, diabetes mellitus (Type I and II), cardiovascular disease, any pathology (or recent surgical event) of the gastrointestinal system or any current metabolic or endocrine disease
• •Alcohol consumption of \> 14 standard drinks for women and \> 21 standard drinks for men per week
• •Currently smoking (have smoked in the last 28 days) or willingness to smoke during the study period
• •Celiac disease or gluten intolerance
• •Use of medications known to influence carbohydrate metabolism, including, but not limited to adrenergic blockers, diuretics, thiazolidinediones, metformin and systemic corticosteroids the last 4 weeks before the screening visit
• •Use of antibiotics during the last three months
• •Reported slimming or medically prescribed diet
• •Unwillingness or inability to comply with the experimental procedures and to follow the safety guidelines